Status:
COMPLETED
Doubling the Iron Dose to Prevent IDA in Twin Pregnant Women
Lead Sponsor:
Ain Shams University
Conditions:
Hematologic Pregnancy Complications
Eligibility:
FEMALE
18-35 years
Phase:
PHASE4
Brief Summary
In twin pregnancies, the maternal iron demands are magnified, estimated at 1.8 times more than in singleton pregnancies due to greater maternal red blood cell mass and plasma volume expansion as well ...
Detailed Description
Iron deficiency anemia (IDA) is a very prevalent condition in pregnancy, affecting nearly 18% of all pregnant women during all three trimesters, with as many as 29%of women affected during the third t...
Eligibility Criteria
Inclusion
- Twin pregnancy.
- Hemoglobin ≥ 10.5 gm/d l. at booking visit
Exclusion
- Continuous hyper-emesis gravid arum lasting beyond 20 weeks of gestation
- Thalassemia minor (alpha or beta).
- Mal-absorption disorders (such as inflammatory bowel diseases, Crohn's disease, ulcerative colitis, previous bowel resection).
- Anemia from chronic illness.
- Any use of multi-vitamin supplements containing iron.
- Any chronic blood loss. e.g: hemorrhoids.
- Autoimmune disorders.
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2020
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT03836703
Start Date
February 1 2019
End Date
August 1 2020
Last Update
January 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ahmed Abass
Cairo, Egypt, 11311